canrenoic acid has been researched along with Hyperaldosteronism in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (78.95) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (21.05) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albiger, N; Armanini, D; Fiore, C; Mattarello, MJ; Sartorato, P; Scaroni, C | 1 |
Armanini, D; Fiore, C; Pellati, D | 1 |
Jacobelli, A | 1 |
Denis, B; Dimitriou, R; Machecourt, J; Page, E; Reboud, JP; Wolf, JE | 1 |
Kuntz, E | 1 |
Haschke, F; Parth, K; Wimmer, M | 1 |
Hirose, H; Kawashima, Y; Matsuda, H; Nakano, S; Nomura, H; Ohtani, M; Shirakura, R; Taniguti, H | 1 |
Brazzarola, P; Degan, M; Delva, P; Lechi, A; Montesi, G; Pastori, C | 1 |
Ogawa, R; Watanabe, T | 1 |
Corvol, P; Freifeld, M; Mahoudeau, J; Menard, J; Michaud, A | 1 |
Chisaka, E; Fukuma, M; Imamura, T; Kashiwagi, S; Sasaki, J | 1 |
Claire, M; Corvol, P; Menard, J; Michaud, A; Rafestin-Oblin, ME; Roth-Meyer, C | 1 |
Ambrosioni, E; Magnani, B; Pasetti, L; Tartagni, F | 1 |
Bräuninger, HJ; Gorbach, HC | 1 |
Ciaccio, S; Coltorti, M; Corsini, R; Radaeli, E; Trebbi, R | 1 |
Ambrosioni, E; Tartagni, F | 1 |
Dupont, A | 1 |
Cuppone, R; Emili, M; Ricci, GL | 1 |
Kiyose, H; Nagano, M; Tagawa, H; Tanaka, S; Umezu, M; Yamakado, M | 1 |
1 review(s) available for canrenoic acid and Hyperaldosteronism
Article | Year |
---|---|
Spirolactones: clinical and pharmacologic studies.
Topics: Aldosterone; Animals; Binding, Competitive; Canrenoic Acid; Canrenone; Diuresis; Humans; Hyperaldosteronism; Hypertension; In Vitro Techniques; Kidney; Mineralocorticoid Receptor Antagonists; Pregnadienes; Protein Binding; Rats; Receptors, Cell Surface; Spironolactone | 1977 |
4 trial(s) available for canrenoic acid and Hyperaldosteronism
Article | Year |
---|---|
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate.
Topics: Adult; Aldosterone; Blood Pressure; Canrenoic Acid; Electrolytes; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System | 2005 |
[Hyperaldosteronism in the acute phase of myocardial infarction. Effects of its treatment on the prevention of ventricular fibrillation].
Topics: Acute Disease; Adult; Aged; Anti-Arrhythmia Agents; Canrenoic Acid; Clinical Trials as Topic; Female; Heparin; Humans; Hyperaldosteronism; Male; Middle Aged; Myocardial Infarction; Pregnadienes; Spironolactone; Ventricular Fibrillation | 1984 |
Suppression of surgical hyperaldosteronism by potassium canrenoate during gynecologic surgery under sevoflurane anesthesia.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Anesthesia, Inhalation; Anesthetics, Inhalation; Blood Pressure; Canrenoic Acid; Female; Gynecologic Surgical Procedures; Humans; Hyperaldosteronism; Intraoperative Complications; Male; Methyl Ethers; Mineralocorticoid Receptor Antagonists; Potassium; Renin; Sevoflurane; Sodium | 2000 |
Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
Topics: Aldosterone; Canrenoic Acid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperaldosteronism; Liver Cirrhosis; Liver Function Tests; Male; Pregnadienes; Random Allocation; Spironolactone | 1988 |
14 other study(ies) available for canrenoic acid and Hyperaldosteronism
Article | Year |
---|---|
Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate.
Topics: Aged; Canrenoic Acid; Dose-Response Relationship, Drug; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Remission, Spontaneous; Time Factors; Treatment Outcome | 2007 |
[Treatment of hyperaldosteronism].
Topics: Adrenal Cortex Diseases; Canrenoic Acid; Female; Humans; Hyperaldosteronism; Male; Spironolactone | 1984 |
[Disorders of water and electrolyte equilibrium in liver diseases. Part 3: therapy (author's transl)].
Topics: Ascites; Benzothiadiazines; Canrenoic Acid; Diuretics; Humans; Hyperaldosteronism; Liver Diseases; Sodium Chloride Symporter Inhibitors; Spironolactone; Water-Electrolyte Imbalance | 1982 |
Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
Topics: Adolescent; Aldosterone; Canrenoic Acid; Child; Child, Preschool; Heart Defects, Congenital; Hematocrit; Humans; Hyperaldosteronism; Infant; Mineralocorticoid Receptor Antagonists; Postoperative Complications; Potassium; Sodium; Spironolactone | 1981 |
[Preventive measures against postoperative secondary aldosteronism following open heart surgery--planned administration of injective aldosterone antagonist].
Topics: Adult; Aged; Canrenoic Acid; Cardiac Surgical Procedures; Drug Administration Schedule; Female; Humans; Hyperaldosteronism; Hyperkalemia; Injections, Intravenous; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Postoperative Complications; Premedication; Preoperative Care | 1987 |
Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis.
Topics: Adult; Aldosterone; Antiporters; Calcium; Canrenoic Acid; Case-Control Studies; Female; Homeostasis; Humans; Hyperaldosteronism; In Vitro Techniques; Lymphocytes; Magnesium; Magnesium Deficiency; Male; Middle Aged; Mineralocorticoid Receptor Antagonists | 2000 |
Antiandrogenic effect of spirolactones: mechanism of action.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Binding, Competitive; Canrenoic Acid; Cell Nucleus; Cyproterone; Cytosol; Dihydrotestosterone; Hyperaldosteronism; Hypertension; Male; Prostate; Rats; Receptors, Cell Surface; Spironolactone; Tritium | 1975 |
[A case of primary aldosteronism associated with spironolactone inclusions (author's transl)].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Canrenoic Acid; Female; Humans; Hyperaldosteronism; Inclusion Bodies; Paranoid Disorders; Spironolactone | 1975 |
[Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
Topics: Canrenoic Acid; Drug Evaluation; Humans; Hyperaldosteronism; Pregnadienes | 1979 |
[Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
Topics: Administration, Oral; Aged; Blood Pressure; Body Weight; Canrenoic Acid; Female; Heart Failure; Humans; Hyperaldosteronism; Injections; Liver Cirrhosis; Male; Natriuresis; Potassium; Pregnadienes; Sodium; Spironolactone | 1975 |
[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
Topics: Adult; Aged; Ascites; Canrenoic Acid; Drug Evaluation; Drug Therapy, Combination; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Hyperaldosteronism; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Pregnadienes; Water-Electrolyte Imbalance | 1976 |
[The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
Topics: Adult; Aged; Canrenoic Acid; Drug Evaluation; Female; Humans; Hyperaldosteronism; Injections, Intravenous; Male; Middle Aged; Pregnadienes | 1976 |
Disappearance of spironolactone-induced gynaecomastia during treatment with potassium canrenoate.
Topics: Canrenoic Acid; Gynecomastia; Humans; Hyperaldosteronism; Male; Middle Aged; Pregnadienes; Spironolactone | 1985 |
Extrarenal role of aldosterone in the regulation of blood pressure.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension, Renovascular; Kidney; Middle Aged; Vascular Resistance; Vasoconstriction | 1988 |